ABSTRACT
Background: Approximately 15 % of couples are affected by infertility, which is defined as the inability to conceive after 12 months of regular unprotected sexual intercourse. Magnetic resonance imaging (MRI) can be used to evaluate congenital Müllerian duct anomalies and to diagnose adenomyosis, leiomyoma and endometriosis. MRI-hysterosalpingography (MR-HSG) in addition to conventional MRI (with/without contrast) is effectively used in diagnosing the tubal and uterine cause of infertilities. Materials and methods: The purpose of study was to evaluate the ability of magnetic resonance hysterosalpingography to evaluate fallopian tube patency and evaluate cause of infertility. Written informed consent was obtained from all subjects. Forty two women with infertility were recruited between 2017 and 2018. Eighteen out of 42 patients had already underwent conventional hysterosalpingography. MRI was performed on a 1.5-T System, using a phased array surface coil. Results: About 32 patients showed bilateral tubal patency. Six patients showed bilateral tubal occlusion on MR HSG. 2 patients had unilateral tubal occlusion. 7 patients had ovarian endometriosis, 6 had leiomyomas, 2 patients had mullerian anomalies, 3 patients had features of polycystic ovarian disease and 5 patients had multifactorial etiology. No cause could be found in 9 patients. Conclusion: MR-HSG is a feasible, useful, innovative and well tolerated tool for the assessment of the uterus, fallopian tubes, ovaries and extra-uterine structures. MR-HSG is a new promising imaging approach to female infertility. MR-HSG scanning can be helpful in demonstrating tubal patency even in patients with documented tubal blockage on conventional HSG.